United States· US:82381-2174_057c1420-60f7-4a86-922c-44b37df317f6
BRENZAVVY
A bexagliflozin product containing bexagliflozin, registered in United States by TheracosBio, LLC.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- Bexagliflozin
- Manufacturer
- TheracosBio, LLC
- Country
- United States (US)
- ATC code
- A10BK08
- ATC class
- Bexagliflozin
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 12, 2026
Packs & prices · 2
- ndc11823812174130 TABLET in 1 BOTTLE (82381-2174-1)
- ndc11823812174290 TABLET in 1 BOTTLE (82381-2174-2)
Regulatory notes
Same medicine, other countries
Bexagliflozin in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/73aa01f0-6146-4062-b038-1469e1f2940b GET /v1/drugs/73aa01f0-6146-4062-b038-1469e1f2940b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unii": {
"unii": "EY00JF42FV",
"rxcui": null,
"inchikey": "BTCRKOKVYTVOLU-SJSRKZJXSA-N",
"display_name": "BEXAGLIFLOZIN",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "ORAL",
"livertox": {
"summary": null,
"livertox_id": null,
"hepatotoxicity_score": 5
},
"spl_meta": {
"3cdf28fc-4194-4ad6-aa03-c9eaa68da83e": {
"match": "brand_token",
"title": "BRENZAVVY (BEXAGLIFLOZIN) TABLET [THERACOSBIO, LLC]",
"spl_version": "8",
"published_date": "2025-11-20"
}
},
"productid": "82381-2174_057c1420-60f7-4a86-922c-44b37df317f6",
"productndc": "82381-2174",
"dosage_form": "TABLET",
"orange_book": {
"appl_no": "214373",
"products": [
{
"rs": true,
"rld": true,
"te_code": null,
"strength": "20MG",
"product_no": "001",
"approval_date": "Jan 20, 2023"
}
],
"appl_type": "N"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "BEXAGLIFLOZIN",
"proprietary_name": "BRENZAVVY",
"active_ingred_unit": "mg/1",
"application_number": "NDA214373",
"marketing_category": "NDA",
"nonproprietary_name": "Bexagliflozin",
"start_marketing_date": "20230713",
"active_numerator_strength": "20"
}See everything about bexagliflozin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.